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Abstract 
 
This is a prospective, case control out patient based study was 
conducted, at Fath ElRahman Elbashier refered clinic, Ibin Sina 
Hospital and Khartoum North Hospital and Khartoum Teaching 
Hospital in the period April 2007 to June 2007. 
In this study, serum level of calcium, phosphate, uric acid and 
urine creatinine, calcium, phosphate, uric acid pH, and urinary 
crystal count for calcium oxalate, phosphate and urate was 
counted in 40 stone formers and 15 non stone formers control. 
The objective of this study was to determine the difference 
between stone formers and non stones formers and also the 
difference between recurrent stone formers and single stone 
formers in urine and blood chemistry. 
The results was compared between stone formers and control and 
recurrent stone formers against single stone formers, and also the 
effect of urinary pH on crystallization on calcium oxalate, 
phosphate and urate. The study concluded that there was 
statistically significant increase in the level of serum calcium, 
urinary calcium/ creatinine ratio, uric acid/ creatinine ratio, urinary 
calcium oxalate count/ HPF and also urate crystals/HPF among 
stone formers compared to control. 
The study also shows a significant increase in the level of urinary 
calcium, urinary ca/cr ratio, urinary calcium oxalate count/HPF, 
phosphate crystal/HPF and urate crystals count/HPF in recurrent 
stone formers compared to single stone formers. 
The study show a significant increase in phosphate crystallization 
with increase urinary pH and increase in urate crystallization of 
urate with a decrease in urinary pH. 
Finally this study recommends the use of analyte/ creatinine ratio 
instead of 24 hours urinary collection, and the use of urinary 
crystals counts to monitor the management of patients with urinary 
stones. 
Finally we recommends that a large prospective study should be 
carried to monitor all factors involved in stone formation e.g 
oxalate  excretion to generalize these findings, and use them in 
management of urinary lithesiasis. 
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1.1. Epidemiology: 
 
 
1.1.1. Historical aspects: 
Stone formation in the urinary tract has been known to occur for 
many centuries. The oldest stone was recovered from an old 
Egyptian grave and has been estimated to be 6.000 year old. In 
the Hippocratic Oath of the medical profession a stone disease is 
the only specifically mentioned by name (Neither will I cut them 
that have stone but leave this operation to those who accustomed 
to perform it. 
It seems likely that this particular attention was caused both by the 
fact that stone formation was common but also that surgical cure 
was difficult and associated with a high degree of complications. 
In the Sudan, calculi of both upper and lower urinary tract are 
common throughout the country with exception of the Southern 
region. It is of interest to note that the first  pyelolithotomy  on 
record in the Sudan was performed in 1931 on Sudanese boy of 
13 years at Khartoum Hospital.        
1.2. Physicochemical aspects on stone formation: 
 
Stone formation in the urinary tract can be caused by many 
different and variable disturbances. To understand the formation of 
stones within the urinary tract one may look upon stone formation 
as a physicochemical problem, even if the basic mechanisms are 
not yet known in most cases. Since most kidney stones consist of 
calcium containing concernments. 
The most common types of kidney stones are shown in Table 1. 
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The most frequently occurring kidney stone consists of calcium 
oxalate, which may be present in different crystalline forms. 
 
Table (1) composition of stones from Sudan (34) 
 
 Upper tract stones 
% 
Lower tract stone 
 % 
Calcium oxalate 5.6 37.8 
Calcium oxalate + calcium 
phosphate  
12.2 0. 
Uric acid 2.4 8.1 
Urate 0 2.7 
Calcium oxalate+ uric acid 4.8 29.7 
Calcium oxalate + urate 0 8.1 
MAP 0 8.1 
MPA+ calcium phosphate 4.8 0 
MAP + calcium phosphate+ 
Ca oxalate 
0 8.1 
MAP- Urate + calcium 
phosphaste 
0 2.7 
Cystine 0 2.7 
MAP    =Magnesium ammonium phosphate. 
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Calcium phosphate occurs in the form of brushite (see Figure 1), 
hydroxyapatite or carbonate apatite. The so-called infection-
induced stones consist of magnesium ammonium phosphate or a 
mixture of this salt with calcium phosphate or calcium oxalate. 
Stones which consist of uric acid or cystine are less common. 
Many kidney stones, perhaps the majority, consist of a mixture of 
different salts. 
1.2.1. Theories of stone formation: 
One condition for the formation of a calcium containing 
concernment in the urinary tract is that the relation between 
saturation of the urine and the activity of inhibitors is changed 
(Figure 2). 
 
 
 
 
 
 
 
 
 
 
 
Figure (1) Brushite crystal (CaHPw4). The name brushite comes from the word brush. 
The picture was taken with scanning electron microscopy. (Kindly provided by Profes 
sor Lynwood H. Smith.) 
Figure (2) Schematic model of the mechanisms for formation of 
calcium containing kidney stones. 
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When the urine is so saturated that the solubility product is 
exceeded there is a risk of precipitation of crystals which then can 
form crystal aggregates and grow to a concrement. 
The degree of supersaturation (see Figure 2) is determined by the 
ion activity product of the salt. If salt is added to the solution, the 
ion activity product increases until a final limit is reached, when a 
salt starts to precipitate. The solubility product is then formed and 
the solution is saturated with respect to this salt. A solution can be 
more or less saturated for some time. However, the precipitation 
and the growth of crystals may occur within this so-called 
metastable region, if a nidus of crystallization is present. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.2.3. Are kidney stones a multifactorial disease? 
 
It is quite obvious (see Figure 3) that there are several possible 
mechanisms for the formation of calcium containing stones in the 
urinary tract. The two most important factors which influence the 
risk of calcium containing stone formation are how much the urine 
is supersaturated with respect to calcium oxalate and calcium 
Figure (3) Schematic picture of different saturation 
 regions for a solution  
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phosphate on the one hand, and the activity of inhibitors on the 
other. If the relation or the balance between super saturation and 
the activity of inhibitors is changed or disturbed , the risk increases 
that crystals will form in the urine. These crystals may then grow, 
aggregate and form stones in the urinary tract. Therefore it is most 
probable that the formation of kidney stones is a multifactorial 
disease. 
The degree of saturation of the urine with respect to calcium salts 
is related to the excretion of calcium oxalate and calcium 
phosphate, and also related to the urinary pH. Both saturation and 
inhibitor activity are related to several other factors, which may 
influence the risk of stone formation. Several such factors are 
known to increase the risk of stone formation, namely a low 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Urinary volume, a high urinary pH, an increased excretion of 
calcium, oxalate and uric acid or a low excretion of glycosagino-
glycans which act as inhibitors to crystallization.( Figure 4) shows 
Figure (4) The relative risk of stone formation in relation to 
abnormalities (in standard deviations) from the mean of anormal 
population for such risk factors as calcium, oxalate, pH, 
glycosaminoglycans and uric acid.  (From Robertson & Peacock, 1978)   
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the relative risk of stone formation in relation to these known risk 
factors. 
When assessing the risk of stone formation in single patient it is 
important to remember that there is no clear cut limit between 
stone formers and healthy persons with respect to these risk 
factors. Nevertheless, the urine of stone formers more often is 
shown to be more supersaturated than the urine of healthy control 
subjects. If abnormalities in several of these known risk factors can 
be demonstrated for one single stone former it is probable that the 
risk of stone formation is increased. The risk factors shown in 
Figure 5 are considered to be of different significance for the stone 
formation process. Robertson and Peacock (1978) have shown 
that abnormalities in oxalate excretion are of greater relevance 
than abnormalities of uric acid, pH and calcium in the urine with 
respect to stone formation. 
Abnormalities in the excretion of glycosaminoglycans are also 
considered to be of great importance for inhibitory activity and for 
the risk of stone formation. Since an increased amount of uric acid 
in the urine is considered to be able to bind glycosaminoglycans, 
the activity of the inhibitors can be reduced. This mechanism may 
therefore increase the risk that calcium containing stones will form. 
Changes of urinary pH are probably less relevant to the formation 
of calcium oxalate concernments but high urinary pH values 
facilitate the formation of calcium phosphate stones. 
1.4.1. Kidney function and renal stone disease: 
Patients with recurrent renal stone formation usually have a normal 
glomerular filtration rate. In addition, renal stone disease is a very 
rare diagnosis among patients accepted for hemodialysis or renal 
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transplantation (European Dialysis and Transplantation 
Association - EDTA, 1980). (1) Studies of kidney function in patients 
with recurrent renal stone formation have been performed much 
less than studies of the physicochemical composition of the urine. 
Recently, however, there have been some reports of renal tubular 
by function in stone formers.(2) The frequency of disturbed tubular 
function varies in different reports and there are few investigations 
covering several tubular functions in larger non selected patient 
materials.(3) To some extent, discrepancies between studies might 
be a reflection of the different methods used. 
1.4.2 Glomerular filtration rate: 
Glomerular filtration rate is usually normal in patients with kidney 
stone disease, unless some complications occur. 
However, when renal function was investigated by inulin clear-
ance in a smaller number of patients with more severe stone 
disease, it was found that as many as 30% of the patients had a 
decreased filtration rate.(4) A small but important group of patients 
in risk of developing end stage renal disease (ESRD) are those 
with nephrocalcinosis due to oxalosis, renal tubular acidosis or 
sarcoidosis.(5) (they all comprise less than 1%). 
More common is the problematic group of patients with recurrent 
urinary tract infections, above all patients with infection-induced 
stones.(6) Other complications which could be deleterious for the 
kidney function are obstructions, repeated operations, sometimes 
with reduction of the renal parenchyma "or nephrectomy".  
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1.4.3 Tubular function: 
 
In several studies based on diagnoses for a large number of stone 
patients, renal tubular acidosis is usually the only one mentioned 
among tubular disturbances. This diagnosis is found in 4-6% of the 
stone formers. However, this figure refers only to the complete 
form of renal tubular acidosis. Only rarely has the acidification 
capacity been systematically investigated in greater, consecutive 
patient materials. In cases where detailed investigations of the 
renal function have been performed, defective acidification 
capacity has been found in about 20% of the cases  
1.4.4 Defective acidification: 
A defective acidification capacity can engage either of the two 
systems. A disturbance of the proximal tubules triggers increased 
excretion of bicarbonate in the urine. If the defect is localized to the 
distal tubules there will be a reduced excretion of H+ ions. Mixed 
forms may also exist, affecting both proximal and distal tubules. 
With more sophisticated methods of investigation and with the help 
of experimental studies, it has been possible to distinguish several 
subclasses of the distal defect. 
1.4.5a Distal acidification defect (dRTA): This type is often 
called the classical form of renal tubular acidosis (RTA, type I). 
The urine is relatively alkaline (pH never below 5.5, usually 6.0 or 
more). The disturbed excretion of H+ ions also implies disturbances 
in the tubular handling of other ions. In particular, there will be an 
increased urinary excretion of potassium and hypokalemia, a 
common complication in the complete form of RTA. Another 
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characteristic finding of the disorder is a massive stone formation 
which may be in the form of nephrocalcinosis which is capable of 
damaging the renal parenchyma. If RTA is not treated the 
glomerular filtration may be affected, and this could lead to chronic 
renal failure. 
1.4.6 b Proximal acidification defects: Are described as being 
part of more extensive tubular damages such as Fanconi's 
syndrome. 
In children, proximal acidification defect has been described as a 
single phenomenon, either as sporadic cases or as hereditary 
disorders. Most of these cases have had a metabolic acidosis and 
the defect has usually been reversible. The defect is also 
described in patients with hyperparathyroidism and chronic 
pyelonephritis. Usually this defect is not considered to predispose 
to stone formation. However, patients with renal stone formation 
have only rarely been systematically investigated as to the 
existence of a proximal defect. Interestingly from the point of view 
of stone formation, patients treated with acetozolamide (Diamox®) 
can develop a proximal acidification defect. Several cases have 
been described, where the stone disease became worse during 
such therapy. 
1.4.7. Stone promoting factors in RTA: 
As described above one of the consequences of defective acidi-
fication is alkaline urine. This alkaline urine increases the risk of 
formation of calcium phosphate stones. When there is a decreased 
excretion of H+ ions as in dRTA, the body tries to compensate for 
the acidosis through increased release of buffer. To a great extent, 
this is taken from the skeleton in the form of calcium carbonate. As 
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a result, there will be an increased excretion of calcium in the 
urine. However, the hypercalciuria in RTA might also be the direct 
effect of acidosis on the tubular reabsorption of calcium.(7) In the 
incomplete forms of RTA, the possibility of renal leakage seems 
slight as there is also a hyperabsorption of calcium going on, as in 
the case of idiopathic stone formers.(8) Quantitatively, the calcium 
excretion in both of these defects is roughly the same. 
Another stone promoting factor in RTA is low urinary excretion of 
citrate. The excretion of citrate is usually regarded to be lowest 
during acidosis.  
1.4.8. Tubular proteinuria: 
 
A sensitive method of assessing tubular affection is to study 
tubular proteinuria. Several small molecular proteins such as 
lysozyme, insulin and beta-2-microglobulin have been used as 
indicators.(9) Some studies have been performed on stone formers, 
but the patient materials have been relatively small.(10) The high 
molecular uromucoid, or Tamm-Horsfall glycoprotein, which is 
produced by the renal tubules, has also been studied. 
There is no uniform opinion among investigators as to whether 
tubular proteinuria is a finding which is characteristic of renal stone 
formers. Some investigators have found a high excretion whereas 
others have found normal excretions. The stone disease might 
also be important as increased excretion has been observed in 
active stone formers, but not in inactive ones. 
Tubular abnormalities in renal stone disease can possibly be 
regarded as a functional disturbance of renal tubules, which seems 
to be reversible in several cases. At present it is uncertain whether 
tubular proteinuria can progress to affect other tubular functions. 
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In patients with RTA tubular proteinuria is much more common 
than in idiopathic stone formers. This suggests more extensive 
tubular affection. 
The high molecular glycoprotein, or Tamm-Horsfall protein, is 
excreted in small amounts in several renal diseases and has also 
been considered to constitute the matrix of renal stones. Only a 
few investigations of this protein have been performed in renal 
stone formers. Some investigations in the past have shown that 
stone patients had an increased excretion. Later studies have not 
confirmed this finding. On the contrary, they have indicated a low 
excretion in stone formers. Stone formers with RTA and those with 
frequent recurrences especially exhibited low excretions. 
1.4.9. The capacity to concentrate and dilute the urine: 
 
The renal ability to concentrate the urine is easily damaged in 
several renal diseases and in some electrolyte disturbances as 
hypercalcimia. Usually the damage is reversible. In a few studies 
on small stone patient materials the concentration capacity was 
found to be normal Out of 41 patients investigated, 33 had a urine 
osmolality of more than 800 mosmol/1 after one night's thirst. If 
one considers the urine volume that many stone formers produce 
spontaneously, rarely more than 2.1L/24 h, this to some extent 
contradicts a diagnosis of severely reduced concentration 
capacity. In contrast, relatively low urine volumes, less than 1L/24 
h, are often found in several stone formers. The dilution capacity 
investigated in 100 patients was found to be reduced in a small 
number of cases. Some of these patients also had other tubular 
disturbances and usually had more severe stone disease. Patients 
with a defective dilution capacity also had great problems in 
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increasing their fluid intake due to subjective discomforts in the 
form of swelling and headache. In patients with spontaneously low 
urine volumes, the possibility of a dilution defect should be 
considered. 
1.4.10. Tubular reabsorption of electrolytes: 
Calcium. An increased excretion of calcium is found in about 30-
40% of renal stone formers and is considered to be of importance 
for stone formation. In some patients, the increased calcium 
excretion is considered to be due to a renal leakage of calcium. 
The typical finding in such cases is an increased calcium excretion 
after fasting and evidence of hyperparathyroidism.  
Other authors also consider renal hypercalciuria to be relatively 
uncommon in renal stone formers.  
Phosphate: Idiopathic stone formers have since long been con-
sidered to have hypophosphatemia due to defective absorption of 
phosphate in combination with hypercalciuria. However, there is no 
simple direct relation between the hypophosphatemia and the 
hypercalciuria. The defective reabsorption is most pronounced in 
patients with RTA who also have the lowest serum phosphate. In 
addition, there is often tubular proteinuria in patients with a 
reduced reabsorption of phosphate. This favors the view that a 
defective tubular handling of phosphate is a common finding in 
recurrent renal stone formers. 
1.5.1. ANATOMICAL ABNORMALITIES IN RENAL STONE 
FORMERS: 
In most larger reports of stone formation, anatomical abnormalities 
are mentioned rather briefly, chiefly in connection with discussions 
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of surgical procedures. The frequency of these abnormalities and 
the clinical picture of patients affected are not much discussed in 
the literature.(11) The more extensive descriptions are almost 
exclusively found in studies of stones during childhood. This raises 
the question of whether there may not be good reason to study 
patients with anatomical abnormalities in more detail and whether 
some special consideration should be taken concerning therapy.  
1.5.2. Occurrence: 
In the total stone patient material from previous studies anatomical 
abnormalities were found in 5% of the patients. Some of these 
abnormalities are probably more important than others in 
considering causes of stone formation, e.g. hydronephrosis and 
ureterocele which cause a stasis of the urine as shown in table 2. 
 
TABLE (2): Occurrence of anatomical abnormalities of the 
upper urinary tract in 36 stone formers investigated (32) 
Anatomy Men Women Total 
Stricture of the ureter 6 0 6 
Congenital hydronephrosis 8 5 13 
Ureterocele 3 0 3 
Horse shoe kidney 2 0 2 
Double ureters and pelvices 8 4 12 
 27 9 36 
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TABLE (3): Occurrence of anatomical abnormalities of the 
lower urinary tract in 68 stone formers investigated  
 
Senile prostate  57 
bladder neck stenosis 7 
Urethral stricture 3 
Foreign body 1 
 
From SMJ vol. 15 1977 
1.6.1. MEDULLARY SPONGE KIDNEY: 
In medullary sponge kidney there is a dilatation of the collecting 
tubules taking the form of cysts. Schematically the picture looks 
like that in Figure 5. Owing to its typical appearance in X-ray 
pictures the abnormality is called sponge kidney. The etiology is 
not known but it is most probably a congenital abnormality, and the 
morphological changes are presumed to be present already at 
birth. The cystic changes are usually well visualised on an 
intravenous pyelography, although the findings sometimes are 
difficult to interpret and the differential diagnosis to, for example, 
nephrocalcinosis can be hard to evaluate.(12) With the so-called 
infusion tomography it has been possible to visualise slighter 
Dilatations of the collecting tubules not yet taking the form of cysts. 
These smaller changes have been called tubular ectasias and 
have been considered by some authors to be of great importance 
for the stone formation. 
1.6.1. Occurrence: 
The typical changes in medullary sponge kidney were first de-
scribed in 1939 by the Italian author Lenarduzzi. A thorough 
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description was given in 1959 by the Swedish authors Ekstrom, 
Engfeldt and Lagergren who reported on 44 cases. They described 
 
 
 
 
 
 
 
 
 
 
 
The X-ray picture as well as the clinical picture and the metabolical 
abnormalities found in medullary sponge kidney. 
As the most important symptoms are due to stones, researchers 
have looked for medullary sponge kidney in recurrent stone for-
mers. The frequency is usually considered to be low, between 2-
4% in greater stone materials if only the typical picture of 
medullary sponge kidney is considered.(13) However, if also the 
tubular ectasias are included the frequency is increased 
considerably, and with the more sensitive X-ray methods, it is as 
high as 25%.It is doubtful whether it is meaningful from the clinical 
point of view to try to diagnose these smaller changes. 
1.7.1. INFECTION-INDUCED STONES: 
 
Since ancient times, the association between urinary tract infec-
tions and renal stone formation has been well-known. Hippo-krates 
realised there was an association between renal stones and 
perinephritic abscesses and recommended surgical treatment of 
Figure (5) Schematic picture of medullary sponge kidney. The 
cystic formations are localized near the papilla 
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these infections, which was performed by lithotomists. By tradition, 
the treatment of these stones has been surgical and the first 
successful pyelolithotomy was performed by Heinecke in 1879. But 
it was not until the discovery of antibiotics that the surgical 
treatment improved. 
In the beginning of the 19th century (1817), Marcet was able to 
demonstrate a relationship between the production of ammonia in 
the urine and renal stones. Almost 100 years later Brown showed 
that the urea-splitting bacteria Proteus and Staphylococ-cus albus, 
but not Escherichia coli, were associated with the so-called struvite 
stones. A relation has also been shown between poorly 
mineralised gelatinous matrix stones and urea-splitting infections. 
These matrix stones are composed of mucoproteins, 
carbohydrates and crystals of struvite which is a geological 
expression for magnesium ammonium phosphate and triple phos-
phate. With modern crystallographic methods it has been shown 
that infection-induced stones are a mixture of struvite and carbon-
ate apatite (Ca10(PO4) • CO3), Later clinical and experimental 
investigations support the theory that the urea-splitting enzyme 
urease is the lithogenic factor in the formation of struvite and 
carbonate apatite.(14) 
1.7.2. Stone formation in the urease forming urinary tract 
infections: 
Infections caused by bacteria which produce urease should be an 
essential requirement for the formation of struvite stones. Bacteria 
which almost always produce urease first and foremost are strains 
of Proteus. To a lesser extent, strains of Klebsiella, Pseudomonas 
and Staphylococcus albus also produce urease (Table 3). In 
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contrast, E. coli does not seem to do so.(15)In fact, it is a simple 
procedure to analyse urease in bacteria. 
Table (4): Urease producing bacteria 
Gram negative bacteria Percent urease positive 
Proteus vulgaris 99.6 
Proteus mirabilis 98.7 
Proteus morgani 91.8 
Klebsiella pneumonia 63.6 
Pseudomnas aeruginosa 32.6 
Enterobacter aerogenes 2.6 
Escherichia coli 0 
 
1.8. MINERAL METABOLISM: 
 
1.8.1. Primary hyperparathyroidism:  
Among the single identifiable causes of stone formation primary 
hyperparathyroidism (HPT) is of particular importance. Its fre-
quency as a cause of stone formation lies between 2 and 5% in 
different stone materials. Since HPT nowadays is often discovered 
by serendipity, when serum calcium is determined in a wide variety 
of conditions (e.g. health surveys), the fraction of HPT patients that 
have stones is decreasing. While twenty years ago 75% of the 
patients with HPT had renal stones, the corresponding frequency 
during recent years is only around 4% patients with HPT can form 
different types of renal stones. The most common is non specific 
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mixture of calcium oxalate and phosphate which is not different 
from that which is seen in idiopathic stone formation. In older 
materials phosphate was the more dominating component. One 
should be particularly suspicious of the possibility of HPT in a 
patient who forms pure apatite stones. Most patients have only 
single or a few renal stones but sometimes X-ray shows a picture 
of nephrocalcinosis. These patients often have more severe 
hypercalcemia and impaired renal function. Symptomatic stone 
disease, however, is not the rule in these cases. 
Patients with HPT sometimes form stones composed of magne-
sium ammonium phosphate or uric acid. 
Even if renal stones still comprise the most common single 
symptom in primary HPT the pattern of stone disease often is not 
remarkable. Thus, HPT is not much more common among those 
with frequent and multiple recurrences than among single stone 
formers. 
It has been suggested that there are two different pathophy-
siological types of a primary HPT - one with large parathyroid 
adenoma, marked hypercalcemia, impaired renal function and 
bone disease, and rapidly progressive on the one hand; another 
with a more benign course, mild, constant elevation of serum 
calcium and a moderate hyperplasia of the parathyroid glands or 
small parathyroid adenoma. Some researchers believe that these 
two types represent the extremes of a continuous spectrum of the 
disease. 
Stone forming HPT patients often have a long history of the 
disease in retrospect revealing mild or intermittent hypercalcemia 
present during several years. This benign form very rarely pro-
gresses to a more severe variant. 
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1.8.2. Physicochemical aspects of stone formation in HPT: 
It seems likely that in primary HPT just as in idiopathic stone 
formation a number of factors contribute to the formation of urinary 
tract stones (Table 4). Among these factors are an increased 
supersaturation, reduced inhibition and renal tubular acidosis. 
Detailed studies have shown that stone forming patients have 
intestinal hyperabsorption of calcium and elevated levels of active 
vitamin D. They also have a higher degree of suppressibility of 
parathyroid hormone secretion in response to oral calcium loading. 
Table (5): Factors of importance for stone formation in 
primary hyperparathyroidism: 
Increased 
supersaturation 
Increased excretion of calcium   
Oxalate (?) 
                Phosphate 
Reduced inhibition Reduced excretion of magnesium 
               Citrate 
               Pyrophosphate 
Alterations of 
physicochemical 
properties 
Excretion of promoters 
Renal tubular acidosis Alkaline pH 
 
The direct effect of parathyroid hormone on the kidney is an 
increased reabsorption of calcium. A likely explanation for why 
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moderately hypercalcemic patients also have hypercalciuria is that 
their intestinal hyperabsorption causes a suppression of para-
thyroid hormone secretion when serum calcium is elevated after 
the meals. Both these factors accentuate calcium excretion. In-
creased bone resorption is also likely since vitamin D together with 
parathyroid hormone affect mineral bone turnover. 
Parathyroid hormone is phosphaturic and an increased phosphate 
excretion is typical for patients with HPT. The urinary excretion of 
oxalate has only rarely been investigated, but it seems likely that 
oxalate output could also be elevated in these patients. 
Substances with inhibitory properties against stone formation can 
be secreted in urine in reduced amounts. In some cases 
magnesium metabolism is affected and also reduced output of 
citrate and pyrophosphate has been reported. 
It has further been demonstrated that urine from patients with HPT 
is more easily crystallised and aggregated. This is probably due to 
an increased excretion of proteins with capacity to induce 
spontaneous crystallisation, so-called promoters.. 
In rare instances a picture of proximal renal tubular acidosis can 
develop since parathyroid hormone affects renal tubular reab-
sorption of bicarbonate. However, this is an uncommon event in 
primary HPT. 
1.8.3. Mild "normocalcemic" primary hyperparathyroidism: 
The diagnosis of primary HPT in patients with clear 
hypercalceamia and recurrent renal stones is seldom difficult. On 
the other hand it can be almost impossible to identify all patients 
with moderate HPT at the first examination. The concept 
"normocalcemic" HPT includes patients with a total serum calcium 
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within the normal range who when operated are shown to have 
hyper functioning parathyroid tissue. Perhaps a more proper 
designation for most of these cases should be "subtle" 
hyperparathyroidism, since most of them are not strictly 
normocalcemic. Their total serum calcium is just at the upper level 
of the normal range. Spontaneous fluctuations sometimes make 
these patients normocalcemic, sometimes hypercalcemic. Verified 
cases of such subtle HPT are not particularly different from those 
involving clear cut hypercalcemia. Thus, most of them have 
parathyroid adenomas, and hyperplasia is present in only about 
one-fifth of the cases. Postoperatively, serum and urinary calcium 
is reduced, which indicates that the observed parathyroid 
abnormalities have the same pathophysiological meaning as in 
other cases of primary HPT. 
In a strict normocalcemic patient the probability of primary HPT is 
low. It can be tempting, however, to resort to parathyroid surgery in 
a patient with a very difficult stone disease, in an act of 
desperation, even if there is only a slight suspicion of HPT. 
However, our experience clearly indicates that such surgery 
should not be carried out unless the diagnosis is evident. (15) 
Resections of normal parathyroid glands will not improve stone 
disease. 
In the recurrent stone forming patient with indeterminate para-
thyroid function thus common measures to prevent recurrences 
should be undertaken. Thiazides are not contraindicated. Con-
tinued follow-up, with or without medical treatment, will generally 
make the picture more clear within a comparatively short time. 
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1.8.4. Idiopathic hypercalciuria: 
The majority of stone patients have distinctly normal serum cal-
cium values. It has been known for a long time that as a group, 
patients who form calcium containing stones have a high urinary 
excretion of calcium. The designation "idiopathic hypercalciuria" 
has been given to a syndrome including hypercalciuria, hypophos-
phatemia and recurrent renal stones. 
The urinary calcium level is affected by a number of factors such 
as the dietary content of calcium, sodium, phosphate, protein, 
carbohydrates and fibers. There are certain seasonal variations 
and there are differences depending on race and age. These are 
factors which make it difficult to define an exact normal urinary 
calcium level and thereby also hypercalciuria. 
Actually there is no great need to determine an exact limit for 
hypercalciuria. The risk of developing renal stones is linearly 
related to urinary calcium within a wide range. Stone patients and 
stone free individals have urinary calcium values which overlap to 
a great extent (Figure 5). Thus it is not decisive for further 
investigation or treatment whether the patient is classified as 
hypercalciuric or not. 
 
 
 
 
 
 
 
 
 
Figure (6) Urinary calcium excretions in healthy 
subjects, single and recurrent stone formers (17) 
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Excess calcium in the urine can only come from the bone or the 
diet. Some data indicate that patients with renal stones have an 
accelerated bone turnover. However, if the extra urinary calcium 
was derived only from the skeleton the annual losses would 
amount to around 5% of total bone calcium. Such losses would be 
clinically evident within a few years. Stone patients very seldom 
have manifest bone disease even if they have had hypercalciuria 
and renal stones for many years. 
Already this clinical observation suggests that most of the excess 
of calcium in the urine comes from an increased absorption of 
calcium in the gastrointestinal tract. Dietary studies have not 
demonstrated any important differences as regards the consump-
tion of calcium or vitamin D. On the other hand it has been 
reported that stone patients eat less fibre, more protein and more 
refined carbohydrates and fat, which all in different ways can lead 
to hyperabsorption of calcium. 
Balance studies and investigations using calcium isotopes have 
clearly demonstrated that hypercalciuric stone patients also have 
hyperabsorption of calcium. At least in part this appears related to 
higher levels of active vitamine D but it is not excluded that there 
are also other factors contributing to the raised absorption of 
calcium in stone formers. 
In some instances an impaired renal reabsorption of calcium could 
also be of importance. Such a defect would secondarily lead to 
parathyroid stimulation, increased synthesis of active vitamin D 
and raised intestinal absorption of calcium.  
 
 
 24
1.8.5. Phosphate metabolism: 
Stone patients as a group have low serum phosphate values since 
they have a reduced renal tubular reabsorption of phosphate. It is 
unlikely that this tendency in the stone patient is caused by primary 
or secondary HPT. 
Phosphate depletion causes increased urinary calcium through 
mechanisms which involve bone, kidney and intestine. 
Hypophosphatemia is a potent stimulus for the synthesis of active 
vitamin D in the kidney. It was therefore natural to investigate if a 
low serum phosphate in stone patients was of pathogenetic im-
portance for their hypercalciuria. Some investigators report a 
significant inverse relationship between the serum levels between 
phosphate and vitamin D, while other studies do not find any 
correlations between serum phosphate and urinary calcium. (17) 
Stone patients and stone free controls react in a similar way to 
phosphate depletion and phosphate loading. During phosphate 
deprivation urinary calcium is increased in a similar way in the two 
groups, and when phosphate intake is increased urinary calcium is 
likewise reduced. 
1.8.6. Magnesium metabolism: 
Magnesium is in vitro an inhibitor for crystallisation of calcium 
oxalate. In animal experiments it has been demonstrated that 
magnesium depleted rats will develop kidney calcifications. In a 
health survey it also found evidence for an increased risk of stone 
formation in individuals with low urinary magnesium. However, 
kidney stone patients, compared to matched controls, have no 
deviation in either gastrointestinal magnesium uptake or in the 
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concentrations of magnesium in serum, muscle or urine. Thus, 
stone patients do not appear to have a disturbed magnesium 
metabolism. 
Since the crystallization of calcium oxalate could be the result of a 
disturbed balance between supersaturation and inhibition, several 
studies have used magnesium as a preventive measure against 
kidney stones. During long-term therapy serum magnesium levels 
will not be affected while urinary magnesium is immediately and 
constantly increased by approximately 30%. These long-term 
effects are further evidence that there is no magnesium depletion 
in the common renal stone patient. 
1.8.7. OXALATE METABOLISM AND KIDNEY STONES: 
In Scandinavia at least 80% of the kidney stones are calcium 
containing concrements. The majority of stones contain calcium 
oxalate as a primary constituent. The main reason why calcium 
oxalate occurs so often is probably due to the fact that this salt is 
sparingly soluble. Even the urine of healthy persons is often 
supersaturated with respect to calcium oxalate. 
Excretion of oxalate in the urine of healthy persons is about 15-50 
mg (0.17-0.56 mmol) per 24 hours with an average of about 35 mg 
(corresponds to 0.4 mmol/24 h). There appears to be no difference 
between the sexes with respect to oxalate excretion. Several 
investigations have shown that the urine excretion of oxalate in 
kidney stone formers as a group (see Figure 7) is increased, as 
compared with non-stone forming controls. 
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There are several mechanisms which may explain an increased 
oxalate excretion. There may be an increased intake of oxalic acid 
or an increased absorption of oxalate in the gastrointestinal tract; 
or there could be a large intake of substances which are meta-
bolised to oxalate. 
1.8.8. CYSTINURIA: 
Cystinuria is an inherited metabolic disorder, autosomally reces-
sive, and is chemically characterised by a specific aminoaciduria. 
Homozygote individuals excrete significantly raised amounts of 
cystine, lysine, arginine and ornithine. Of these the insoluble 
cystine accounts for the clinical manifestations with stone forma-
tion in the urinary tract. 
In contrast to most cases of idiopathic stone disease cystinuria 
implies a need of lifelong controls, generally with medical treat-
ment in order to avoid severe complications including stone 
formation and impaired renal function. 
Figure (7) Schematic presentation of urine cystine excretion in 
healthy subjects, hetero- and homozygous cystinuria 
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1.8.9. Clinical picture: 
The impaired intestinal absorption and the increased urinary 
excretion of the different aminoacids involved has no apparent 
negative effect from a nutritional point of view. There have been 
reports where cystinuria was overrepresented among patients with 
mental deficiencies and that children with cystinuria had a slower 
growth. 
The main clinical symptoms, however, are related to the reduced 
solubility of the cystine in urine with ordinary pH. When the urinary 
pH is between 4.5-7, the maximal solubility lies around 1.200 
/mmol (Figure 8). Since this is a normal range for urinary pH and 
since homozygote cystinurics often excrete over 3-5 mmol/24 h, 
crystalluria and formation of stones are common. 
Stone formation can occur already at a very early age, but clinical 
symptoms generally are not apparent until after 20 years of age. 
The disturbance of aminoacid handling is equally common among 
males and females in the affected families but males more often 
have stones. In addition, their disease seems more severe than 
that of females. 
 
 
 
 
 
 
Figure (8) Acid- base status in serum and urine in low (L) and 
high (H) protein diet. The dots represent the average in 8 
stone formers observed for 2 weeks on each diet in ametabolic 
ward. The figures are from fellstrom (1981) 
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1.8.10. URIC ACID STONES: 
 
Uric acid and some of its salts are only slightly soluble. This leads 
to an increased risk of precipitation of crystallization within the 
kidney and the urinary tract. Several different clinical syndromes 
involving disorders of uric acid metabolism and impairment of renal 
function are known.  
1.8.11. Clinical aspects of uric acid stones: 
There are great variations in the incidence of uric acid stones. In 
the U.S. and the major part of Europe, this type of concrement is 
about 3 - 5 % of all kidney stones.(26) These stones seem to be 
more common in some countries, notably Israel, Germany, 
Czechoslovakia and France. In Israel there are reports that about 
75% of all kidney stones consist of uric acid. 
Uric acid stones are especially common in patients with gout, and 
particularly in patients with gout coupled with high excretion of uric 
acid. Increased incidence of uric acid stones may also occur in 
patients with gastrointestinal disorders with significant fluid loss 
through an ileoclostomy. These patients have highly concentrated 
acid urine due to bicarbonate loss within the intestine. This results 
in a metabolic acidosis and increased excretion of hydrogen ions. 
Urinary pH is then reduced, through which mechanism the risk of 
precipitation of uric acid increases. 
A third group with increased risk of precipitation of uric acid in the 
urine is comprised of patients who constantly have an acid urine. 
Many of these patients also have some disorder of the purine 
metabolism. Only about 25% of patients with uric acid stones have 
a demonstrable abnormality in purine metabolism. Furthermore, in 
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the majority of patients with uric acid stones, it was only a 
constantly acid urine which could be demonstrated as the 
predisposing factor in stone formation. 
1.8.12. Pathogenesis of uric acid stones: 
 A number of clinical conditions are characterised by increased 
excretion of uric acid (see Table 5). Certain drugs, e.g. probene-
cid and salicylates, induce highly increased but transient excretion 
of uric acid which predisposes kidney stone formation. 
Conditions with increased excretion of uric acid: (TABLE 5)    
Increased excretion without increased purine synthesis: 
a. Increased intake of uricosuric substances, e.g.  salicylate, 
phenylbutazon, probenecid  
b. Purine rich diet 
Increased purine synthesis: 
a. Hereditary enzyme defects, e.g. lack of HGPRT, lack of 
glucose-6-phosphate 
b. Myelo- and lymphoproliferative diseases. 
c. Protein rich food  
d. Ethanol intake  
e. Intake of fructose and lactose. 
f.Obesities. 
An overproduction of urate can be seen in certain rare enzyme 
deficiency conditions. More common are myelo- or lymphoproli-
ferative diseases as causes of overproduction. The most common 
cause is a diet which is rich in animal protein. An increased intake 
of ethanol, fructose and lactose may also result in increased 
excretion of urate. 
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Even if the formation of uric acid concrements and the passage of 
such stones are often the most predominant symptoms, two other 
conditions should also be mentioned, namely crystalluria of uric 
acid and obstruction of the collecting tubules. It is difficult to 
estimate how often pronounced crystalluria - which may show 
clinical symptoms occurs. Small crystal aggregates may pass as 
gravel and the patient may have symptoms such as dysuria, 
hematuria and at times even of renal colic. These symptoms may 
constitute initial stages of renal colic, which may be caused by a 
larger uric acid stone. 
Sometimes hyperuricosuria may be caused by chemotherapy or 
radiation therapy of malignant tumors, e.g. during treatment of 
meyloproliferative diseases. Obstruction may then occur in the 
urinary tract because of precipitation within the collecting tubules, 
which in turn may result in oliguria and anuria. This type of acute 
renal failure has a good prognosis when treated adequately. 
1.8.13. Composition of uric acid stones 
With modern analytical techniques it has been possible to find 
three different crystalline forms of uric acid in kidney stones.(28) The 
most common crystalline form is uric acid without crystal-bound 
water. Recently, crystals consisting of uric acid with crystalline 
water, uric acid dihydrate, have also been found in uric acid 
stones. However, these crystals are usually not stable but lose 
their crystalline water. In certain uric acid concernments, some 
stabilising factors appear to be present to prevent the evaporation 
of crystalline water from dihydrate crystals. 
Uric acid stones often have a yellow-orange colour since uric acid 
may bind several different substances in the urine, e.g. different 
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colour pigments containing pyrrol rings.(28) The significance of 
these colour pigments for the formation of uric acid stones is so far 
unknown. 
In patients with recurring urinary tract infections and constantly 
alkaline urine, stones consisting of ammonium hydrogen urate may 
occur. These stones are formed according to the following 
scheme: infections in the urinary tract due to microorganisms, 
which have the enzyme urease, split urea and form ammonia as a 
result of the action of urease. This will result in an increased 
urinary pH and this will lead to an increased risk of the precipitation 
of ammonium urate. Ammonium hydrogen urate is very insoluble 
(about 55 mg/1). The diagnosis of urate stone is significant, since 
the treatment with alkaline, which often is used as a treatment of 
uric acid stones, should not be used for the treatment of urate 
stones. 
1.8.14. HYPERURICOSURIA AND CALCIUM CONTAINING 
KIDNEY STONES: 
In patients with uric acid stones, pathogenetic mechanisms such 
as an abnormality in the acidification of the urine or an increased 
urinary urate excretion are often the probable causes of stone 
formation. Recently, disorders of the urate metabolism have been 
related to the formation of calcium oxalate concrements. This 
syndrome, which has been called hyperuricosuric calcium oxalate 
stone disease, has above all been described in the U.S.A. 
Several reports have demonstrated a relation between high 
incidence of uric acid disorders and the incidence of calcium 
containing kidney stones. Several reports have shown that patients 
with gout often form kidney stones consisting of calcium 
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oxalate.(29)Dent and Sutor found that hyperuricemia was more 
common in calcium oxalate formers than in healthy controls. That 
these patients could form a particular group of kidney stone 
patients was first described in 1969 by Smith and co-workers. 
Recently Coe and collaborators have observed that a high urate 
excretion in the urine was most common in stone formers with 
calcium oxalate stones and that this finding probably was of 
significance for the formation of stones. 
1.8.15. Pathogenetic mechanisms of hyperuricosuria: 
An increased excretion of urate or uric acid in the urine is often 
caused by a diet rich in meat. Other causes of overproduction of 
uric acid may be malignant diseases and rare enzymatic disorders. 
Some rare cases of a hereditary defect in the renal handling of 
urate have also been described, where a defect of the tubulary 
absorption of urate may be the cause. This will lead to a low serum 
level of urate, hyperuricosuria and the formation of uric acid 
stones. 
1.8.16. How can urate in urine affect calcium oxalate 
precipitation? 
In the Western world the high excretion of uric acid in the urine is 
probably due to increased intake of animal protein. In order to 
reduce urate excretion, it may be advisable for stone formers to 
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become vegetarians. Since animal protein will also in crease the 
urinary excretion of calcium and probably augment excretion of 
oxalate as well, the supersaturation of calcium oxalate in the urine 
will increase. It is also conceivable that a high level of urate 
excretion is only an indication of high protein intake. In this case, 
the urate may have no pathogenetic significance concerning stone 
formation. 
Several different hypotheses have been proposed to explain how 
urinary urate should facilitate precipitation, crystal growth and 
aggregation of calcium oxalate. One of the mechanisms proposed 
is that sodium urate crystals should induce the growth of calcium 
oxalate crystals by so-called epitaxis. This theory is based on 
crystallographic studies, where it has been possible to show a 
great similarity between monosodium urate and calcium oxalate 
crystals. The fact that there are kidney stones containing both 
urate and calcium oxalate is thought to provide additional support 
for this theory.(30)However, a prerequisite for the theory is that a 
Figure (9) The excretion of different ions in the urine on protein rich 
diet (142 g) compared with excretion on a low protein diet (57g). The 
bars represent the average excretion in relation to excretion on a low 
protein diet. 
TA= titrable acid; Urat = urate    
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precipitation of sodium urate crystals is present in the urine, and 
this seems to be an uncommon finding due to the high solubility of 
urate in the urine. 
Another possible mechanism is that sodium urate could bind 
certain of the inhibitors of the urine, namely the 
glycosaminoglycans. This would mean that urate would reduce the 
effect of the inhibitors and thereby increase the risk of 
crystallisation and aggregation of calcium oxalate crystals. Several 
of these glycosaminoglycans have a strong inhibitory effect on 
calcium oxalate aggregation. This is true, for example, in heparin 
and chondroitin sulphate, but the question is if these glycosami-
noglycans are present in the urine in amounts that would have any 
substantial effect in vivo. 
1.12.5. Renal handling of urate in kidney stone formers: 
Hyperuricosuria has been considered a risk factor in the formation 
of calcium containing kidney stones. Since certain hyperuri-cosuric 
patients cannot reduce their excretion of urate at a low urine 
intake, this could mean that certain patients may have a defect in 
the renal handling of urate.(31) Since certain kidney stone patients 
have signs of other tubular dysfunctions, such as a defective 
acidification of the urine (above all a proximal defect, which leads 
to an increased bicarbonate excretion), disorders in the renal 
handling of urate are also conceivable. 
At the present time urate is thought to be transported within the 
kidney in the following way: In the glomeruli there is in principle a 
practically free filtration of urate, followed by a reabsorption of 
about 98-99% of the filtered urate.(32)There is also a tubular 
secretion of urate followed by a so-called postsecretory 
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reabsorption (see Figure 10). By inhibition of the tubular excretion 
of urate with pyrazinamide (PZA) it is possible to study the filtration 
of urate, which is normally reabsorbed. This was studied in a 
number of kidney stone formers. It was then shown that in kidney 
stone patients who had hyperuricosuria, it was not possible to find 
any defects in the renal handling of urate. Patients with so-called 
proximal acidification defect, on the other hand, had a higher 
tubular reabsorption and low excretion of urate than healthy 
controls. It was thus not possible to find any signs that defects in 
the kidney should lead to a higher excretion of urate than in cases 
where patients had hyperuricosuria. It was more probable that the 
high excretion of urate in certain stone formers was due to high 
production of uric acid due to an increased intake of animal 
protein. 
Figure (10) Schematic model of the renal handling of 
urate. From Fellstrom (1981) 
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 Justification 
 
 
As shown above, results of urinary analysis and blood 
biochemistry is often abnormal in patient with urinary stones. 
Investigating and interpretation of these tests will help a lot in 
prevention of stones formation and follow up of patients who on 
treatment. 
Since early nineteen eighties no study was carried on urinary or 
blood biochemistry of stone formers in Sudan this study for 
renewal of these findings and to compare our finding with them.  
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Objectives 
 
• To study the difference in urine and blood chemistry between 
stones and non stone formers. 
• To assess the difference between recurrent stones formers 
and single stone formers in  blood analytes concentration 
,urine analytes concentration & urine crystals count / HPF. 
• To assess the effect of pH on crystals formation within urine. 
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2. Methodology 
 
 
2.1. Study design area and duration: 
 
This is prospective case control out patient study conducted at 
Khartoum state, during the period from May 2007 to June 2007. 
2.2. Studied population: 
The studies include patients who had diagnosed renal stone or 
surgically removed stone (stone formers) and matched 15 non 
stone formers. 
2.3. Inclusion criteria:  
Patients with renal stone and control patient with no history of 
stone the study carried in adulthood age > 18 years. 
2.4. Exclusion criteria: 
• Patient with renal failure. 
• Patient with obstructive uropathy. 
2.5. Tools: 
2.5.1. Consent: 
Verbal consent was taken from administration, treating doctors 
patients or their relatives. 
2.5.2. Questionnaire: 
A questionnaire (appendix 4) was designed containing data 
regarding the personal data; name, age, sex tribe and residence of 
the patients. It also contains clinical information such as clinical 
diagnosis, and duration of illness and recurrence of stones. 
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2.5.3. Study protocol:  
Forty patients with renal stone and fifteen nonstone formers as 
control, underwent estimation of their urine calcium creatinine 
ratio, phosphate/ creatinine ratio, uric acid/ creatinine ratio and 
urinary pH and urine microscopy was done. 
2.5.4. Methods of urine collection: 
Fifty milliliter of early morning urine was collected, it was divided 
into two containers, one is used for analytical chemistry and the 
other centrifuged and the deposit examined under the microscope 
for semi-quantitative measurements of crystals number.  
2.5.5. Method of blood collection:  
Blood was collected from patients under aseptic conditions. Five 
mls of venous blood were taken by a disposable syringe into 
heparenized container. Grossly lipaemic or haemolysed sample 
were excluded. 
2.5.6. Semi quantitative measurements of urine and serum 
analytes: 
a. Calcium measurements: 
• Principle of the procedure: Colorimetric end point assay, dye 
binding method; it is based on formation of colored 
compound between calcium and 0, cresolphataleiun. 
 
Ca+2+0- cresolphatacin           colored complex 
 
The intensity of the color is proportion to the concentration of 
calcium in the sample. 
Heparin zed plasma. 
Urine collected in clean, blastic calcium free containers. 
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Urine diluted 1:2 with distilled water. 
b. Creatinine measurements: it is based on Jaffe reaction which 
is photometric colorimetric endpoint test with deproteinization. 
principle: Creatinine forms on alkaline solution an orange red 
color complex with picric Acid with intensity proportion to the 
concentration of creatinine in the sample . 
Creatinine + picric acid    OH        Creatinine picric acid complex 
Specimen: Heparnized plasma, urine is diluted to 1:49 then the 
result multiplied byX50. 
• Haemolysed sample is discarded & the collection is 
repeated. 
• Temperature was kept constant for samples and STDS. 
• Urine is boiled for 5-7 minutes to eliminate other reducing 
substances. 
c. Uric acid measurement: Enzymatic end point colorimetric 
method. 
Principle: Uric acid in the sample is oxidized to allantoin and 
hydrogen peroxide in the presence of uricase. The liberated 
hydrogen peroxides detected by achromgenic acceptor in the 
presence of peroxides. The red quinine formed is proportional to 
the amount of uric acid present in the sample. 
Uric acid + 2H2O +O2           Allantoin  CO2 + H2O2   
H2O2 + dichlorophenal + 4 AP  Pex     Quinone +2H2O  
Sample: Serum or plasma 
Urine: 1:9 dilution with distilled water the and result multiplied by 
10 when urine is turbid it is warmed to about 60oc for 10 minutes to 
dissolve the uric acid 
d. Phosphate estimation: end point dye binding colorimetric 
method. 
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Principles:  phosphate reacts with molybdate in strong acid 
medium to form a complex. The absorbance of this complex in the 
near UV (340nm) is directly proportional to phosphate 
concentration in the sample. 
7H3PO4+12 (MO7O24)6 + 51 H+       (P(MO12 O4)3 + 36 H2O 
Specimen: Hepernized plasma measurement wave length: 340 
nm, Temp 20-25c0. Urine must be diluted 1:9 with distilled water 
and result multiplied by x 10. 
2.5.7. Microscopic urinalysis: 
Methodology: 
A sample of well mixed urine (10-15mls) is centrifuged in a test 
lube (≈2-3000pm) for 5-10mn minutes until moderately cohesive 
buffoon in produced at the bottom of the tube. The supernatant is 
decanted and a volume of 0.2- 0.5ml is left inside the tube. The 
sediment is resuspended in the remaining supernatant by flicking 
the bottom of the tube several times. 
A drop of resuspended sediment is poured onto a glass side and 
cover slipped: 
The sediment examined for various types of crystals and described 
as the number of each type found per high power field (HPF).  
2.5.8. Urinary pH estimation: 
- Sample; 50ml of urine. 
- Instrument: General purpose pH/mv/Temperature 
Benchmeter. 
The pH value is directly related to the ratio of hydrogen ion (H+) 
and the hydroxyl ion (OH-) concentration. If the concentration of H+ 
ion is greater than OH- the material is acidic ,with pH value lesser 
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than 7. And if the concentration of OH- is greater than H+ the 
material is basic, with the pH value greater than 7. If the 
concentration of H+ and OH are equal the material is neutral with a 
pH of 7. 
pH measurement: 
a. Calibration was performed using automatic temperature 
compensation. 
Then the electrodes immersed into urine and the pH 
measurement displayed on the screen. 
Principle: when indicator and referee electrode was immersed 
into urine current was created the amount of which is directly 
proportion to the concentration of Hydrogen ions in the sample 
and displayed on screen in digital number with 0.01 resolution. 
Quality control:  
1. During use the electrode was rinsed between 
each measurement to eliminate continuation 
relation. 
2. Buffers were kept tightly closed to prevent air 
pollution. 
3. Fresh buffers should be used. 
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Results 
 
Forty patients with urinary calculi, and fifteen without urinary calculi 
, age and sex matched control subjects were studied using 
cloromeric photometeric measurements of their urinary excretion 
of calcium, phosphate and uric acid. And their plasma levels of 
calcium, phosphate and uric acid. Also the number of different 
crystals in their urine was counted by average high power field 
were compared in addition to their urinary pH was measured using 
pH meter. 
Characteristic of the studied patients: 
3.1.1. Age distribution: 
Among the studied patients the ages ranges from 19-86 year, with 
a mean of 40.7 and standard deviation of 16.6 years. 70% (28 
patients) between 41-65 years 25% (10 patients) more than 65 
years and 5.1 % (20 patients) below 20 years). 
3.1.2. Sex characteristics of the studied patients:  
Thirty four patients 85% are males and only six (15%) are female, 
with male to female of about 6:1. 
3.1.3. Stone formation:  
25 patients (62.5%) had recurrent stone. While 15 patients (37.5) 
patient with first time stone formation. 
Urinary calcium phosphate and uric acid among studied patients: 
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3.1.4. Urinary calcium excretion:  
The mean of urine calcium among studied population is 3.4 
mmol/L with standard deviation (STD) of 0.75mmol/L and ranges 
between 2.00 – 4. 70mmol/L. With 22.5% lies between 3.6 and 4.0 
and 20% between 2.6 to 3.6, 20% between 3-1 to 3.4mmol and 
15% between 4.1 to 4.5, 12.5% between 2% to 2.5 and only 10% 
more than 6.4 mmol/L figure (11)   
3.1.5. Urinary uric acid excretion: 
 Among studied patients the mean uric acid execution is 6.5 with 
STD of 1.3 and ranges between 4.5 and 9.00 µmol/L, and 
described as follows 27.5% between 5.1 to 6.0 mmol/L, 17.5% 
between 4.5 and 5, 12.5 between 6.1, 6.5 12.5 between 2.14, 7.5, 
10% between 6.6, 7.0 while only 7.5% between 7.6 to 8.0 and 
other7.5% between8.1 to 8.5 and 8.6-9 Figure (12). 
3.1.6. Urinary phosphate excretion:  
The mean phosphate excretion is 19.2 mmol/L with STD of 5.4 and 
range between 10.2- 36.00mmol/L. With 30% of patients excrete 
11.6-18.9mmol and another 30% between 19.0-23.3, 20% excrete 
10.2 to 14.5mmol and 12.5% excrete 23.4 to 27.7 and 5% excrete 
32.2 to 36.5 and only 2.5% excrete 27.8 to 32.1mmol/L of 
phosphate in urine Figure(13).    
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Urinary excretion of calcium, phosphate and uric acid ratio to 
creatinine excretion (Ca/Cr ratio, p and u/cr ration): 
3.1.7. Calcium/ creatinine ratio (ca/cr ratio):  
The mean ca/cr ratio is 0.5 with STD of 0.061 and range from 0.41 
to 6.0. . With 30% excrete 0.4to 0.45 and 25% between 0.46- 0.50 
and other 25% excrete 0.56 to 0.60 and only 20%lies between 
0.51 to 0.55mmol/L Figure(14)  . 
3.1.8. Phosphate/ Creatinine ratio (P/cr ratio):  
The mean P/cr ratio is 2.82 with STD of 0.48 and range between 
2.0 to 3.4. With 32.5% of patients lies between 3.2 to 3.5 and 
27.5% between 2.8 to 3.1 and 22.5% between 2.0 to 2.3 and 
17.5% between 2.4 and 2.7mmol/L Figure (15)   . 
3.1.9. Uric acid/ creatinine ratio( U/cr ratio):  
The mean U/cr ratio is 0.97 with STD 0.27 and range between 
0.45 and 1.95µmolL. With frequency of 50% patient between 0.75 
to 1.06 and 27.5% between 1.07 to 1.37 and 17.5% between 0.45 
to 0.75 and 2.5% between 1.38 and 1.68 and other 2.5% of 
patients lies between 1.69 to 1.99mmol/LFigure (16) 
3.1.10. History of infection:  
Only 6 patient (5.1%) has positive history of infection while the 
majority 34 patient (85%) has no history infection. 
3.1.11. Family history of stone formers: 
Only 4 patients 10% has family history of infection while 36 has no 
family history of infection. 
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3.1.12. Urinary pH:  
The mean of urinary pH among stone former in the studied 
population is 6.39 with STD of 1.27 and range between 4.25 and 
6.30.  
Blood level of calcium, phosphate and uric acid among 
studied patients. 
31.13. Blood calcium:  
The mean blood calcium level is 2.50 mmol/L and STD of 0.20 and 
range between 2.10 to 2.90mmol/L. 9 With the majority 65% lies 
between 2.38 to 2.79 and 30% between 2.10 to 2.37 and only 5% 
between 2.8 and3.0 mmoL/L Figuer (17) 
3.1.14. Blood phosphate:  
The mean blood phosphate level is 1.21mmol/L with STD 0.26 and 
range between 0.77 and 1.66 mmol/L. With 17.5% lies between 
0.77 to 0.92 and 17.5% between 0.93 to 1.08 and 20% between 
1.09 to 1.24 and 12.5 between 1.25 to 1.40 and 25% between 1.41 
to 1.56 and only 7.5% between 1.57 to 1.75mmol/L Figure(18)    
3.1.15. Blood uric acid:  
The mean uric acid level is 5.78 µmol/L with STD of 1.23 and 
range from 3.70 to 8.00 µmol/L. With 30% lies between 6.1 to 6.8 
and 20% between 4.5 to 5.2 and 17.5% between 3.7 to 4.4 and 
15% between 5.3 to 6.0 and 12.5 between 6.9 to 7.6 and only 5% 
between 7.6 to 8.3mmol/L Figure(19)   . 
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Urinary crystal count among stone formers in the sample 
studied: 
3.1.16. Urinary phosphate crystals counts:  
The average number of phosphate crystal per HPF in stone former 
was found to be 1.43 crystal/HPF with STD of 2.21 and range 
between zero and 9 crystal/ HPF. With 52.5% of patient excrete no 
crystals and 27.5 excrete 1 to 2 crystals and 10% 3 to 4 and 5% 5 
to 6 and 2.5% excrete 7 to 8 and another 2.5% excrete 9to10 
crystals/HPF Figure (20)  . 
3.1.17. Urinary calcium oxalate crystals count:  
The mean excretion of calcium oxalate is 15.63 among stone 
formers with STD of 10.14 and range between 4-50 crystal/ HPF. 
With the following frequencies 40% lies between 4to11 crystals/ 
HPF and 35% between 12to19 and 12.5% between 28 to 35 and 
10% between 20to27 and 5% between 43 to 50 and only 5% lies 
between 36 to 42 crystal/HPF Figure (21). 
3.1.18. Urinary urate crystals count:  
The mean urinary urate excretion among stone former is 
2.35crystals /HPF will STD of 3.89 and range between zero and 14 
crystals per HPF. With 47.5% has no crystals in their urine with 
zero per cent has 1-3 and 15% with 4to6, 10% with 7 to 9, 5% has 
10 to 13 and only 2.5% has 14to17 crystals/ HPF in their urine 
Figure (22). 
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3.2 Characteristics of control group:  
3.2.1. Age distribution:  
The mean age of control subject was found to be 41.5 years with 
STD of 16.2 years and range between 19&72 years Figure (23). 
 Urinary excretion of calcium, phosphate and uric acid among 
control group. 
3.2.2.Urinary calcium excretion: 
The mean urinary calcium is 3.4 mmol/L with STD of 0.47 and 
range between 2.7-4.1 mmol/L. with 20% of controls excrete 2.7 to 
2.9 mmol/L of calcium and other 20% excrete 3.0 to 3.2, 27.7% 
excrete 3.9 to 4.1, 20% has 3.6 to 3.8 and 13.3% excrete 3.3 to 
3.5mmol/L Figure (24). 
2.2.3. Urinary uric acid excretion:  
Among control group the mean urinary acid is 6.30 µmol/L with 
STD of 1.61 µmol/L and range between 3.9-8.6 µmol/L. One 3rd 
33% of controls has 4.8 to 5.6mmol/L of uric acid in their urine and 
26.7% has 7.5 to 8.3, 13.3% has 3.9 to 4.7, 13% 5.7 to 6.5 and 
13.3% has 8.4 to 9.2 and no one excrete  6.6 to 7.4mmol/L . 
Figure (25).    
3.2.4. Urinary phosphate excretion:  
The mean phosphate excretion was found to be 19.4 mmol/L with 
STD of 7.4 mmol/L and range between 10.8-36 mmol/L. Near half 
of the controls 46.7% has 10.8 to 15.0mmol/L in their urine and 
26.7% has 19.4 to 23.6, 6.1% between 15.1 to 19.3, 6.7% at 23.7 
to 27.9, 6.6% of 28.0 to 32.2 and 6.7% at  32.3  to 3 6mmol/L  in  
their  urine  Figure (26). 
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Urinary excretion of calcium, phosphate and uric acid ratios to 
creatinine excretion (Ca/cr, P/cr U/cr ratios). 
3.2.5. Calcium creatinine ratio) Ca/cr ratio): 
 The mean Ca/cr ratio is0.44 and STD 1.34 and range between 
0.31 and 5.1. There is 20% of control has 6.37 to 0.39 Calcium 
creatinine ratio and 13.3% at 0.40 to 0.41, 13.4% of 0.46 to 4.7 
and 13.3 at 0.48 to 0.49 and 13.3% lies between 0.50 to 
0.51Figure (27). 
3.2.6. phosphate creatinine ratio: 
(P/cr ratio) the mean P/cr ratio is 2.27 and STD of 0.90 and range 
between 0.32 to 3.7 mmol/L. 26.7% of the urine has phosphate to 
creatinine ratio of 2.03 to 2.5 in there urine while 20% has 1.46 to 
2.02 and other 20% with 2.6 to 3.12, 13.3% has 0.89 to 1.45 and 
13.3% has 3.13 to 3.07 and only  6.7%  has  0.32  to  0.88  
phosphate  to creatinine ratio Figure (28) . 
 
3.2.7. Uric acid creatinine ratio (U/cr ratio):  
The mean U/cr ratio is 0.89 mmol/L and STD of 0.29 and ranges 
between .40 to 1.5mmol/L.  33.4% control has uric acid creatinine 
ratio of 0.61 to 0.81 while 26.6% has 0.82 to 1.02 and 13.4% has 
1.03 to 1.23 and 13.3% has 0.4 to 0.6 and 6.6% has 1.24 to 1.44 
and 6.7% has 1.45 to 1.65 uric acid to creatinine ratio Figure (29). 
3.2.8. History of infection: 
Only 2 subject, had history of infection while the majority  has no 
history of infection. 
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3.2.9. Family history of stone formation: 
 No one of control group has family history of stone formation. 
3.2.10. Urinary pH:  
The mean urinary pH of control group is 5.90 with STD of 1.14 and 
range between 4.1 to 8.90. Figure (30). 
3.2.11. Blood calcium:  
The mean blood calcium was found to be 2.31 mmol/L with STD of 
0.11 and range between 2.0-2.74mmol/L.  With 40% of control has 
serum calcium range between 2.13 to 2.25 and 13.4% from 2.26 to 
2.38, 13.3% rage from 2.39 to 2.51 and 13.3% with 2.25 to 2.64 
and 13.3% with rage from 2.00 to 2.12 and only 6.7% range 
between 2.65 to 2.77mmol/L Figure (31).   
3.2.12. Blood phosphate:  
The mean blood phosphate level is 1.24mmol/L with STD of 0.23 
and range between 0.86 and 1.61. 3 With 33.3% lie between 1.14 
to 1.27 and 20% between 1.28 to 1.4 and 13.4% between 1.06 to 
1.13 and 13.3% between 0.86 to 0.99 and other 13.3% between 
1.56 to 1.69 while only 6.7% range between 1.42 to 1.55mmol/L. 
Figure (32). 
3.2.13. Blood uric acid:  
The average uric acid excretion among control was found to be 
5.31 µmol/L and STD of 1.16 and range between 3.50 to 7.10 
µmol/L  With the following range 33.3% between 5.6 and 6.2, 20% 
between 4.2 to 4.8 and other 20% ranges from 3.5 to 4.1 and 
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13.3% between 6.3 and 6.7 and 6.7% between 4.9 and 5.5 and 
other 6.7% between 7.0 and 7.6mmol/L Figure (33) . 
Urinary crystal count in control group: 
3.2.14. Calcium oxalate crystal:  
The average count of calcium oxalate crystal was found to be 2.2 
crystal/ HPF and STD of 2.24 and range between zero and 7.0 
crystal/ HPF.  With one 3rd (33.3%) has no crystal, and 13.4% has 
1 and 13.3% has either 2,3,4 and 5 and 6.7% has 4 and other 
6.7% has 6 crystals/ HPF Figure (34). 
3.2.15. Urinary phosphate crystal count:  
The mean urinary phosphate crystals was found to be 0.73/HPF 
and STD of 1.16 and range between 0.00 to 4 crystal/HPF.  60% 
has no crystal, 20% has one and 13.3% has 2 and 6.7% has 4 and 
no one has 3 crystals/HPF Figure (35)  . 
3.2.16. Urinary urate crystal, count:  
The average urate crystals within the control group was found  to 
be 0.33/HPF with STD of .62 and range between zero to 2.0 
crystals/HPF.  73.3% of control sample has no crystal, and 20% 
has one crystals and only 6.7$ has 2 crystals of urine acid/HPF in 
their urine Figure (36). 
3.3. Compression between stone formers and control group: 
3.3.1. Urinary calcium:  
The mean urinary calcium of stone former is 3.46 and that of 
the control is 3.4mmol/L, so there is no significant 
difference between them.P value > 0.05 Figure (37). 
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3.3.2. Urinary uric acid:  
The mean uric acid excretion for the stone formers is 6.56 and 
that of the control is 6.3 mmol/L, there is no significant 
difference between them with P. value of 0.59. Figure (38). 
3.3.3. Urinary phosphate: The mean phosphate excretion 
among stone formers is 19.2 and that of nonstone 
formers is 19.4 mmol/L, with P value of 0.91, so there is 
no significant difference  between them Figure (39).    
3.3.4. Calcium creatinine ratio: calcium ratio is significantly higher 
within stone formers with a mean of 0.5 while that of control 
is 0.44 with P. value 0.001 Figure (40). 
3.3.5. Phosphate/creatinine ratio: the mean p/cr ratio among 
stone former is 2.82 and control group is 2.27 there P. 
value is 0.61 so there  difference  is  not  significant  
Figure (41) . 
3.3.6. Uric acid /creatinine ratio: The mean UA/cr ratio in 
stone formers is 0.97 while in control it is 0.89 with P value of 
0.05, so   it  Is  significantly   high  among  stone  formers  
Figure (42).  
 
3.3.7. Urinary pH: The mean urinary pH of patient is 6.33 and 
control 5.9 with P. value of 0.13 so there is no significant 
difference Figure (43). 
3.3.8. Blood Calcium: Blood calcium mean for stone formers is 
2.5mmol/L and of control is 2.31mmol/L with P. value of 0.004 
so it is higher in patients Figure (44). 
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3.3.9. Blood phosphate: The mean blood phosphate for stone 
formers is 1.21 and control is 1.24mmol/L with P.value of 
0.63 so the difference is not significant.  Figure (45). 
3.3.10. Blood uric acid: The mean level for stone formers is 5.18 
mmol/L and for control is 5.31 with P value of0.21, so the 
difference is not significant Figure (46). 
  .3.3.11. Urinary phosphate crystal count: The mean among 
stone former is 1.43 and that of control is 0.73 crystals/H 
PF with P. Value of 0.23 so it is not significantly higher 
among stone formers Figure (47). 
3.3.12. urinary calcium oxalate count: the mean for stone 
formers is  2.35 and for control is 0.33 with P value of 0.05, 
it is significantly high in stone formers Figure (48) .  
3.3.13. Urinary urate crystals: count the mean for stone formers 
is 2.35 and for control is 0.33 crystals/H P F with P value of 0.05 
so of is significantly high in stone formers Figure (49). 
3.4. Compression between recurrent stones former and single 
stone former 
3.4.1. Urinary calcium: The mean for recurrent stones formers 
is 3.65 while that of single stone formers is 3.28mmol/L 
with P. value of 0.05 so if is significantly high among 
recurrent stones formers Figure (50) . 
3.4.2. Urinary Uric acid: The mean urinary urate excretion 
among recurrent stones formers is 6.36mmol/L and that of 
single stone former is 6.8mmol/L with P. value of 0.08 so there 
is no significant difference between the two groups Figure (51). 
3.4.3. Urinary phosphate: The mean urinary phosphate is 
19.22mmol/L for the recurrent stones former and 19.23 for that 
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of single stone formers with P. value of 0.07. so there is no 
significant difference Figure (52). 
3.4.4. Calcium creatinine ratio: The mean urinary ca/cr ratio 
for recurrent stones formers is 2.84 and 2.79 mmol/L for single 
stone former with P.value of 0.01 so it is significantly higher 
within recurrent stone formers Figure (53). 
3.4.5. Phosphate/creatinine ratio: The mean urinary P/Cr ratio 
for recurrent is 2.84 and 2.79mmol/L for single stone formers 
with P. value of 0.68 so three is no significant difference 
between the groups Figure (54). 
3.4.6. Urate/ creatinine ratio: the mean U/Cr ratio among 
stone formers is 0.93 and  that of single stones formers is 1.04, 
with P. value of .13 so there is no significant difference between 
the two groups Figure (55). 
3.4.7. Serum calcium: the mean serum calcium for recurrent 
stones former is 2.25 and 2.45mmol/L for single stones former 
with P. value of 0.16 so there is no significant difference 
between the two groups Figure (56). 
3.4.8. Serum phosphate: There is no significant difference 
between the two with a means of 1.21 for recurrent stone 
formers and 1.19 for single stone former with P. value of 0.07 
Figure (57). 
3.4.9. Serum uric acid: The mean serum uric acid for recurrent 
stones former is 5.74 and that for single stone former is 5.82 
mmol/Lwith P. value of 0.12 so the difference is not significant 
Figure (58). 
3.4.10. PH: The mean urinary pH for recurrent stones former is 
6.45 and 6.28 for single stone formers, with P. value of 0.12 so 
there is no significant difference. Figure (59). 
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3.4.11. Calcium oxalate crystals count: The mean of calcium 
oxalate crystal/HPF among recurrent stones formers is 17.28 
and 12.87crystals/HPF among single stone former with P. value 
of 0.001 so there is high excretion among recurrent stones 
formers Figure (60). 
3.4.12. Phosphate crystal count: The mean count for 
recurrent stones formers is 1.56 and 1.02 for single stones 
formers with a P. value of 0.03 so if higher among recurrent 
stones formers Figure (61). 
3.4.13. Uric acid crystals: It is significantly higher among 
recurrent stones with a mean of 2.72 compared to 1.73mmol for 
single stone former with a P. value of 0.02 Figure (62).   
3.4.14. The relation between history of infection and 
urinary pH: 
 
83% of patient, with history of infection lead a pH of more than 
7.5while only 17% had a pH of less than 6. Figure (63). 
3.5. The effect of urinary pH on different analytes excretion: 
3.5.1. Calcium  creatinine ratio: 
The is no significant effect of urinary  pH on calcium creatinine 
ratio with P value of more than 0.05. Figure (64). 
3.5.2. Phosphate creatinine ratio: 
There is no significant effect of urinary pH on phosphate/ 
creatinine   ratio with P value of more than 0.05 Figure (65). 
3.5.3. Uric acid/ creatinine ratio:  
There is no significant effect of urinary pH on uric acid excretion 
with p value of more than 0.5 Figure (66). 
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3.6. The effect of urinary pH on urinary crystals count:  
3.6.1. Urinary phosphate crystals count: 
There is very significant effect of urinary pH on phosphate 
crystallization with p value of 0.02. That is the higher the pH the 
more phosphate crystal, formation Figure (67). 
3.6.2. Urinary urate crystal count:  
The is significant increase in urate crystals formation with 
increase of pH with p value of 0.05. Figure (68). 
3.6.3 Urinary calcium oxalate crystals count:  
The study show no significant effect of pH on calcium oxalate 
crystallization Figure (69).  
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Discussion 
 
Stone diseases is one of the biggest challenges faced by the 
urologist today, particularly recurrent stones. Despite the 
introduction of non invasive techniques in diagnosing and treating 
stones e.g lithotripsy. 
In this study there is no significant difference in the level of urinary 
calcium execration between stone formers and normal controls in 
spot urine testing, but when we compare urinary calcium excretion 
to creatinine excretion (Ca/cr ratio), there is a significant difference 
between the two groups with high level of ca/cr ratio among stone 
formers. 
No significant different in urinary uric acid between stone formers 
and normal in spot testing  but when uric acid: creatinine ratio was 
compared there is significant difference between the two groups. 
These findings attributed first, to the fact that creatinine excretion 
can be used instead of 24 hrs urine collection, and secondly to the 
instructions given to stone patients to drink plenty of water which 
might result in dilution of urine and falsely hypocalciuria and 
hypouricosuria. There is no significant difference in urinary 
phosphate and phosphate / creatinine ratio among studied patients 
and control groups due to the fact that phosphate excretion is 
affected by presence of high pH and infection with urea splitting 
organism e.g protus and R.T.A. Which little pit rare if compared to 
idiopathic stones former . We found significant difference in the 
level of serum calcium between patient and control, so other 
factors may contribute to this abnormality and predispose to stone 
formation e.g hyperparathyroidism. But there is no significant 
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difference in the blood level of phosphate and uric acid between 
stone formers and control groups. 
The study show very significant different in urinary calcium oxalate 
crystals excretion between stone former and non stone formers 
which may signify that hyperoxalouria is an important frequent 
findings for stone formation, also there is significant difference in 
uric acid crystal excretion but insignificant difference in phosphate 
crystal excretion between the studied patient and control sample. 
When we compare recurrent stone former with single stone 
formers we found significant difference between the two groups in 
the level of  calcium excretion. But there is no significant difference 
in the level of urinary uric acid and urinary phosphate between the 
two groups. 
When we compare calcium creatinine ratio  (Ca/cr ratio) the 
difference became more significant this is due to the fact that both 
group are asked to take plenty of water and standardization was 
achieved by using creatinine as dominator make the difference 
more significant. 
The is no significant different between recurrent stone formers and 
single stone formers when blood calcium , blood phosphate and 
blood uric acid were compared. It seem that the persistence of the 
abnormality rather than the level is contributing factor in recurrence 
of stone formation . There is significant different between recurrent 
and single stone formers in the level of Ca/cr ratio but there is no 
significant difference in the p/cr and u/cr ratio. This finding will 
disclose the fact that hypercalciuria is an important factor in stone 
formation and recurrence. 
There is no significant different in urinary pH between recurrent 
and single stone formers in studied population. But there is 
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significant difference in the level of calcium oxalate, phosphate and 
uric acid crystals count between recurrent and single stone 
formers.  
We can conclude from the results obtained that urinary pH has no 
obvious effect on the renal handing of the analytes assessed, that 
is to say calcium , phosphate and uric acid  excretion 
On the other hand urinary pH has significant effect on both 
phosphate and uric acid crystallization within urine. The former is 
increased with increased pH, while the later is increased with 
decease in the urinary pH. 
As we can deduce from figure (63) that infection increase the 
urinary pH so it is indirectly increase the formation of phosphate 
crystals, a finding that agrees with many previous research and the 
physiochemical effect of hydrogen ion on phosphate crystallization. 
When we assess the effect of pH on urate crystallization we find 
that the more the acidic the urine the more liability for urate 
crystallization ,so urate stones may  occur when there is 
hyperuricosuria and low urinary PH. As we all know the blood PH 
which has effect on renal handling of urate is regulated at a narrow 
range (7.34-7.43) in normal individual, while the pH of urine is 
markedly change even with in the same day depending on many 
factors like diet, drugs and the ability of the kidney to concentrate 
urine. 
When we compare the result obtained with a study carried by 
A.Kambal .E.M.A Wahab, A-H-H-Khattab and J-zaki  in 1981 
Appendix (3).(34) we find that they agree in that both studies Show 
high level of serum calcium. But they disagree in the that our 
result, show, significant difference In the level of calcium/creatinine 
ratio compared to insignificant difference in 24 hours urine calcium 
 91
between stone formers and northern control. Also our study show 
significant  difference in the level of uric acid /creatinine ratio 
compared to an insignificant difference   in the study carried in 
1981.So we can attribute that difference to the fact that our study 
adopt creatinine for standardization while the other adopt 24 hours 
urine collection which is practically show some difficulties. Another 
factor that may affect the results that the chemicals and reagents  
becoming more pure compared to that in the past ,in addition to 
more sensitive and accurate  machines and the development of 
new precise methods in analysis. 
When we look to our results we find that there is significant 
difference in analytes excreted in stores formers and also 
increased crystallization of their compounds. Here arises difficult 
question is that is these findings is attributed to the presence of 
higher concentration of these analytes in urine of stone formers or 
ionization to ions or dissociation into  small crystals of the present 
stone in to the urinary tract. As we knew that molecular form and 
the ionized form are in equilibrium when dissolved in to water 
((ionization coefficient )). Also water will cause dissociation of 
some stones to its different component to form small crystals 
which might affect the number of crystal count. This hypothesis is 
supported by the fact that stones are made of mixture of 
compounds with the dominance of one or two compounds table xx, 
so the hypothesis of ionization and dissociation is supported by 
finding an increased level of different analytes and their crystals in 
the same stone former. So we need amore sophisticated method 
to differentiate between analyses of filtered and those dissociated 
or ionized.                                   
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Conclusion 
  
• This study concluded that there is increased ca/cr ratio, 
phosphate/cr ratio blood calcium, urinary calcium oxalate 
crystal and urinary urate crystals among stone formers 
compared to non stone formers. 
• The study also concluded that there is increased urinary 
calcium, Ca/Cr ratio, calcium oxalate crystals, phosphate 
crystals and urate crystals among recurrent stone formers 
compared to single stone formers. 
• The study also show increase phosphate crystallization 
with increased pH and increase urate crystallization with 
decrease of urinary pH.  
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Recommendation 
 
• Large, prospective, carefully controlled studies are needed 
for assessing the difference in blood and urine biochemistry 
between stone formers and control and recurrent stone 
formers and single stone formers is needed to generalization 
of our findings and use them in management of patients of 
urinary tract stones. 
• The use of creatinine for standardization of urinary testing 
and finding a cut off level of the normal level of analytes/ 
creatinine ratio. 
• The use of analytes/ creatinine ratio is rapid easy cheap, 
accurate method should be assessed and introduce in 
urology clinic to follow up stone patients. 
• The use of crystal counts which is more sensitive method for 
follow up.  
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Appendix (1) 
 
Comparing Different components analyzed between stone 
formers and non stones formers 
 
Stone formals Normal 
control 
Parameter 
Mean STD Mean STD 
P value 
Urinary Calcium(mmol/L) 3.46 0.75 3.40 0.41 0.933 
Urinaryuric acid(µmol/L) 6.56 1.3 6.30 1.61 0.591 
Urinary phosphate (mmol/L) 19.2 5.4 19.4 7.4 0.911 
Ca/cr ratio 0.5 0.61 0.44 1.34 0.001 
P/Cr ratio 2.82 0.48 2.27 0.90 0.605 
U/cr ratio 0.97 0.27 0.89 0.29 0.05 
Urinary pH 6.39 1.27 5.90 1.14 0.13 
Blood Calcium (mmol/L) 2.50 0.20 2.31 0.11 0.004 
Blood phosphate (mmol/L) 1.21 0.26 1.24 0.23 0.627 
Blood Uric acid(µmol/L) 5.18 1.23 5.31 1.16 0.209 
Urinary phosphate crystal/HPF 1.43 2.21 .73 1.16 0.23 
Urinary calcium oxalate 
crystal/HPF 
15.63 10.14 2.2 2.24 0.00 
Urinary Urate crystals/ 
HPF 
2.35 3.89 .33 .62 0.05 
        
3.5. Between groups study: 
Among the stone formers there was 25 patients with recurrent 
epithods and 15 other with single epithods. 
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Appendix (2) 
 
Comparing different constituents analysed between first time 
stone formers and recurrent stone formers: 
      
Recurrent 
stone formers
 formals 
First time 
stone formers 
Parameter 
Mean STD Mean STD 
PValue 
Urinary Calcium (mmol/L) 3.65 72. 3.28 .78 0.05 
Urinary uric acid(µmol/L) 6.36 1.17 6.80 1.053 0.08. 
Urinary phosphate (mmol/L) 19.22 5.18 19.23 6.00 .07 
Ca/cr ratio 0.514 0.07 0.48 0.06 0.01 
P/Cr ratio 2.84 0.50 2.79 4.49 0.62 
U/cr ratio .93 0.20 1.04 0.35 0.13 
Serum calcium (mmol/L) 2.25 0.23 2.45 16. 0.16 
Serum phosphate (mmol/L) 1.21 0.26 1.19 .25 0.07 
Serum Uric acid(µmol/L) 5.74 1.27 5.82 1.20 0.12 
Urinary pH 6.45 1.3 6.28 1.15 0.12 
calcium oxalate crystal 
count 
17.28 11.28 12.87 7.44 0.001 
Phosphate crystals count 1.56 2.52 1.200 1.61 0.03 
Uric acid crystals count 2.72 4.41 1.73 2.84 0.02 
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Appendix (3) 
     
Table: Comparison between Adult Males with renal stones and 
controls from Northern and Southern Sudan  
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Appendix (4) 
University of Khartoum 
Faculty of Medicine 
Department of Pathology 
Questionnaire about Urinary Stone 
 
 
Serial No………                                              Date:………… 
Condition:…………………………………………………..  
1- Name:…………………………………………………….  
2- Age (years)………………….. 
3- Sex                          a- Male   b- Female 
4- Tribe:…………………………………………………….  
5- Residence………………………………………………  
6- Clinical diagnosis 1- Non stone former        2- first time stone 
formation 
3- Recurrent stone  
7- Duration of illness………………………………………………….  
8. History of schistosomiasis                          Yes                 No 
9. Anatomical abnormalities of urinary tract  Yes                No 
 
10. Mode of treatment 
1. Surgical           2. Lithtotripsy            3. Medical treatment 
11. Family history of Urinary stones 
                                                         Yes                   No 
12. If yes what type 
Upper urinary                                Lower Urinary 
13. Drugs used……………………………………………………… 
14. History of urinary tract infection 
                                                         Yes                   No 
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15. Results of Urine chemistry, minoscopy and blood 
Biochemistry 
 
Calcium/Crealinine ratio  
Phosphate creatinine ratio  
Uric acid creatinine ratio  
pH  
crystal type crystal size  
Serum Calcium (mmol/L)  
Serum phosphate (mmol/L)  
Serum Uric acid (mmol/L)  
  
